August 2016
Volume 11 Issue 8 |
|
|
|
|
ADVERTISEMENT
|
|
Subscribe
Subscribers can enjoy each full issue of Pharmaceutical Technology in print or via the PharmTech app.
subscription offers |
 |
|
|
|
Supply Chain Update
Bribery and corruption may be the latest challenge to supply chain integrity.
/ read more /
Zenith appointed Carlos Machado as serialization director to lead the company's sales, operations, and post project support services.
/ read more /
|
|
|
ADVERTISEMENT
|
The company opened a new service center in San Juan, Puerto Rico.
/ read more /
GenPak Solutions is cited by FDA for cGMP violations at its Hilliard, Ohio facility.
/ read more /
UPS will expand its clinical trial logistics capabilities to include drug and vaccine development.
/ read more /
|
|
|
ADVERTISEMENT
|
API Synthesis and Manufacturing
Recent research of efficient chiral synthesis technologies reveals potential uses in API manufacturing.
/ read more /
|
|
|
Outsourcing Update
Unfavorable public investment markets could put emerging bio/pharma growth and CDMO spending at risk in 2017.
/ read more /
|
|
|
ADVERTISEMENT
Proprietary content and intelligence delivered to your in-box
In-depth analyses. Searchable online databases. Monthly and quarterly newsletters from Jim Miller and his expert staff. All focused on the bio/pharmaceutical outsourcing industry and emerging markets. We keep you informed about what is driving change and how it will impact your business. Learn more about PharmSource STRATEGIC ADVANTAGE today. |
|
|
|
Contract Services Update
The company will expand its service offerings to include oligonucleotide API development and manufacture.
/ read more /
The pen injectors will be produced at Catalent's Brussels, Belgium facility.
/ read more /
The company will invest 18 million Euros in its Kaysersberg facility to expand blow-fill-seal capacity.
/ read more /
The company plans to purchase and develop an 18-acre site in Des Plaines, Illinois.
/ read more /
The company invested $50 million in an expansion at its Charles City, Iowa facility.
/ read more /
EAG Laboratories announces new company identity and intent to expand testing, analysis, and characterization capabilities across multiple markets.
/ read more /
|
|
|
In the Lab
NIST's monoclonal antibody reference material can be used as a standard for biopharmaceutical analytical quality control.
/ read more /
The Nexera-i MT from Shimadzu incorporates two flow lines, which allow for both UHPLC and HPLC analysis.
/ read more /
The company invested in the MicroSeq Rapid Microbial Identification System from Applied Biosystems at its Illinois facility.
/ read more /
|
|
|
|
|